Akin to DNA-based gene therapies, RNA-based therapies are the newest innovation in labs nationwide and have shown immense potential. Interfering with genetic data at the ribonucleic acid (RNA) level gives scientists the ability to intercept a patient’s genetic abnormality before it is translated into functioning (or nonfunctioning) proteins. Today, the most popular and successful mechanisms of RNA therapy include antisense nucleotides and RNA interference. These new therapies are being explored in a variety of rare genetic diseases such as Huntington’s disease, as well as in cancer and neurologic diseases, with the hope of treatment by way of alternate genetic data. These new mechanisms of action are opening windows for progress and innovation in therapeutics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
In this video, learn why RNA-based therapies are one of Cleveland Clinic’s top 10 medical innovations for 2019.
The relationship between MTHFR variants and thrombosis risk is a complex issue, but current evidence points to no association between the most common variants and an elevated risk
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Studying gender-specific health factors promises new insight into diagnosis, prognosis, treatment
Consortium is uncovering risk factors that spur disease development in an understudied group
Cleveland Clinic researchers receive $2 million grant from the National Institutes of Health
New Cleveland Clinic fellowship fosters expertise in the genetics of epilepsy